Zobrazeno 1 - 10
of 77
pro vyhledávání: '"John A. Liu Yin"'
Autor:
Charles Craddock, Robert Kerrin Hills, John A. Liu Yin, Lars Kjeldsen, Nigel H. Russell, Richard E. Clark, Alan Kenneth Burnett, Andrew Howman, Antonio Pagliuca
Publikováno v:
Leukemia. 29:1478-1484
Allogeneic stem cell transplantation (SCT) provides the best mechanism of preventing relapse in acute myeloid leukaemia (AML). However non-relapse mortality (NRM) negates this benefit in older patients. Reduced intensity conditioning (RIC) permits SC
Autor:
Keith Wheatley, Charles Craddock, Sylvie D. Freeman, Lars Kjeldsen, Ann Hunter, Robert Kerrin Hills, Inge Hoegh Dufva, Alan Kenneth Burnett, Donald Milligan, Jonathan Kell, John A. Liu Yin, Nigel H. Russell
Publikováno v:
Journal of Clinical Oncology. 30:3924-3931
Purpose There has been little survival improvement in older patients with acute myeloid leukemia (AML) in the last two decades. Improving induction treatment may improve the rate and quality of remission and consequently survival. In our previous tri
Autor:
John Burthem, John B. Houghton, Simon G. Watt, Eleni Tholouli, Hayley Greenfield, Guy S. Lucas, John A. Liu Yin, Jim Cavet
To the editor: Adult Burkitt lymphoma/leukemia (BLL) is a rare, aggressive B-cell neoplasm with typical morphologic appearances. It is characterized by rapid proliferation of mature B cells (Ki67/MIB-1 staining ≥ 99%) and overexpression of c -Myc,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::622232b0b538a0b497d76c6ddacfc57b
https://ora.ox.ac.uk/objects/uuid:505f90a9-165b-4607-83fb-297af3563c5c
https://ora.ox.ac.uk/objects/uuid:505f90a9-165b-4607-83fb-297af3563c5c
Autor:
Peter Johnston, Ann Hunter, W. Jonathan Kell, Mary Frances McMullin, Michael Dennis, Nigel H. Russell, John A. Liu Yin, Robert Carr, Richard E. Clark, Stefania Paolini, Donald Milligan, Alan Kenneth Burnett, John J. Murphy, Emma Das-Gupta, Robert Kerrin Hills, Dominic Culligan
Publikováno v:
Journal of Clinical Oncology. 28:2389-2395
Purpose Treatment options for older patients with acute myeloid leukemia (AML) who are not considered suitable for intensive chemotherapy are limited. We assessed the second-generation purine nucleoside analog, clofarabine, in two similar phase II st
Autor:
Judith C. W. Marsh, Anna Martin, Inderjeet Dokal, Sarah E. Ball, Jane Keidan, John A. Liu Yin, Jane Mercieca, Rhona Stewart, Sally Killick, Phil Darbyshire, Andrew Laurie, Jamie Cavenagh, Edward C. Gordon-Smith
Publikováno v:
British Journal of Haematology. 147:43-70
King’s College Hospital, St Mary’s Hospital, Barts and The London Hospital, London, Birmingham Children’s Hospital, Birmingham, Barts and The London School of Medicine and Dentistry, St George’s Hospital, London, Queen Elizabeth Hospital, Kin
Autor:
C. Thomas, Huw Roddie, Sproul Am, R. Thomson, John A. Liu Yin, M. Waterfall, M. Klammer, Kay Samuel, Peter R. E. Johnson, A. Atkinson, M Turner
Publikováno v:
British Journal of Haematology. 133:152-157
Twenty-two patients with acute myeloid leukaemia were recruited into a phase I/II clinical trial investigating the vaccination of patients in complete remission (CR) with autologous dendritic-like leukaemia cells (DLLC). At trial entry, leukaemia cel
Autor:
Mamta Garg, Joseph Chacko, Richard E. Clark, Meryem Ktiouet Dawson, Sahra Ali, Adam J. Mead, John A. Liu Yin, Claire N. Harrison, Chris Andrews, Mira Farquharson, Steven Knapper, Dragana Milojkovic
Publikováno v:
British journal of haematology. 170(1)
Myelofibrosis is characterized by splenomegaly and debilitating constitutional symptoms that negatively impact patients' quality of life. ROBUST, a UK, open-label, phase II study, evaluated the safety and efficacy of ruxolitinib in patients with myel
Autor:
Jane Mercieca, Judith C. W. Marsh, Shaun R. McCann, Sarah E. Ball, David Oscier, A.W.W. Roques, A. Martin, A.J. Keidan, Edward C. Gordon-Smith, John A. Liu Yin, P. J. Darbyshire
Publikováno v:
British Journal of Haematology. 123:782-801
Autor:
John A. Liu Yin, Lindsay Frost
Publikováno v:
Current Oncology Reports. 5:399-404
The core-binding factor (CBF) leukemias comprise acute myeloid leukemia (AML) with t(8;21) and inv(16)/t(16;16), characterized by the presence of the AML1-ETO and CBFbeta-MYH11 fusion genes, respectively. These leukemia-associated genes can now be se
Publikováno v:
British Journal of Haematology. 123:49-59
Summary. We have developed a sensitive, competitive, nested reverse transcription polymerase chain reaction (RT-PCR) titration assay that quantifies the number of Wilm's tumour (WT1) gene transcripts in bone marrow (BM) and peripheral blood (PB), cou